Quartic.ai, a manufacturing AI and IIoT platform supplier, and Bright Path Laboratories, a provider of continuous flow reactor technologies, have signed an agreement to develop an AI-powered continuous manufacturing platform for active pharmaceutical ingredients (APIs) and other small molecule drugs.
The agreement will use Bright Path Labs’ continuous bioreactor and the Quartic.ai smart manufacturing technology.
